Preparation and in vitro-in vivo evaluation of double layer coated and matrix sustained release pellet formulations of diclofenac potassium

International Journal of Pharmaceutics

Volumn 406, Issue 1-2, 2011, Pages 84-90

  Fu, Jijun ^a   Wang, Xiaoli ^a   Xu, Lishuang ^a   Meng, Jia ^a   Weng, Yan ^a   Li, Guofei ^a   He, Haibing ^a   Tang, Xing ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Bioavailability; Diclofenac potassium; Matrix; Pellets; Sustained release

Indexed keywords

DICLOFENAC; DICLOFENAC POTASSIUM; EXCIPIENT; POLYMER;

AREA UNDER THE CURVE; ARTICLE; COLON; DOG; DOUBLE LAYER COATED PELLET FORMULATION; DRUG BIOAVAILABILITY; DRUG COATING; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; INTESTINE TRANSIT TIME; MATRIX SUSTAINED RELEASE; MATRIX TABLET; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PELLET EXTRUSION; PRIORITY JOURNAL; SPHERONIZATION; SUSTAINED RELEASE PREPARATION; TABLET FORMULATION;

ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; DOGS; POLYMERS; SOLUBILITY; TABLETS, ENTERIC-COATED;

EID: 79951580453     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.12.043     Document Type: Article

References (55)

1. S. Aoki, K. Uesugi, K. Tatsuishi, H. Ozawa, and M. Kayano Evaluation of the correlation between in vivo and in vitro release of phenylpropanolamine HCl from controlled-release tablets Int. J. Pharm. 85 1992 65 73
2. S. Aoki, H. Ando, K. Tatsuishi, K. Uesugi, and H. Ozawa Determination of the mechanical impact force in the in vitro dissolution test and evaluation of the correlation between in vivo and in vitro release Int. J. Pharm. 95 1993 67 75 (Pubitemid 23203137)
3. N. Billa, K. Yuen, M.A.A. Khader, and A. Omar Gamma-scintigraphic study of the gastrointestinal transit and in vivo dissolution of a controlled release diclofenac sodium formulation in xanthan gum matrices Int. J. Pharm. 201 2000 109 120 (Pubitemid 30364974)
4. D. Brockmeier, H.J. Dengler, and D. Voegele In vitro-in vivo correlation of dissolution, a time scaling problem? Transformation of in vitro results to the in vivo situation, using theophylline as a practical example Eur. J. Pharmacol. 28 1985 291 300 (Pubitemid 15085155)
5. A.J. Coupe, S.S. Davis, and I.R. Wilding Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects Pharm. Res. 8 1991 360 364
6. J.N. Cashman The mechanisms of action of NSAIDs in analgesia Drugs 52 1996 13 23 (Pubitemid 26379062)
7. H.G. Damman, J. Simon-Schultz, I. Steinhoff, A. Damashcke, A. Scmoldt, and E. Sallowsky Differential effects of misoprostol and ranitidine on the pharmacokinetics of diclofenac and gastrointestinal symptoms Br. J. Clin. Pharmacol. 36 1993 345 349 (Pubitemid 23303532)
8. S.S. Davies, J.G. Hardy, and J.W. Fara Transit of pharmaceutical dosage forms through the small intestine Gut 27 1986 886 892 (Pubitemid 16044258)
9. R. Dietrich, R. Brausse, G. Benedikt, and V.W. Steinijans Feasibility of in vitro/in vivo correlation in the case of a new sustained-release theophylline pellet formulation Arzneimittel-Forschung 38 1988 1229 1237
10. I.B. Dressman Comparison of canine and human gastrointestinal physiology Pharm. Res. 3 1986 123 131
11. J. Drewe, M. Keck, P. Guitard, A. Pellet, B. Johnston, and C. Beglinger Relevance of pH dependency on in vitro release of bromocriptine from a modified-release formulation J. Pharm. Sci. 80 1991 160 163
12. L.A.F. Evans, K.A. Norton, M.J. Puz, and S.C. Sutton Use of gamma scintigraphy as a tool in the development of in vitro and in vivo relationships of compound A for controlled release formulations in dogs. American Assoc. for Laboratory. Animal Science National Meeting Indianapolis 1999
13. Fara, J.W., 1985. Gastric emptying and the transit of dosage forms. In: Prescott, L., ed. Rate Control in Drug Therapy, Prescott, L.F., and Nimmo, W.S., eds. Rate Control in Drug Therapy. Edinburgh: Churchill Living-Stone. pp. 144-150.
14. Y. Fukumori Coating of multiparticulates using polymeric dispersions I. Ghebre-Sellassie, Multiparticulate Oral Drug Delivery 1997 Marcel Dekker New York 79 111
15. I. Ghebre-Sellassie Multiparticulate Oral Drug Delivery 1997 Marcel Dekker New York
16. C.K. Gleiten, K.-H. Antonin, P. Bieck, J. Godbillon, W. Schonleber, and H. Malchow Colonscopy in the investigation of drug absorption in healthy volunteers Gastrointest. Endosc. 31 1985 71 73 (Pubitemid 15077694)
17. J.G. Hardy, W.J. Harvey, R.A. Sparrow, G.B. Marshall, K.P. Steed, M. Macarios, and I.R. Wilding Localization of drug release sites from an oral sustained-release formulation of 5-ASA (Pentasa) in the gastrointestinal tract using gamma scintigraphy J. Clin. Pharmacol. 33 1993 712 718 (Pubitemid 23260397)
18. J.A. Herrera, A. Millan, R. Ramos, P. Fuentes, and M. Gonzalez Evaluation of the effectiveness and tolerability of controlled-release diclofenac-potassium versus immediate-release diclofenac-potassium in the treatment of knee osteoarthritis Curr. Ther. Res. 68 2007 82 93 (Pubitemid 47198633)
19. J.B. Houston, and S.G. Wood Gastrointestinal absorption of drugs and other xenobiotics J.W. Bridges, L.F. Chausseaud, Drug Metabolism vol. 4 1980 Wiley Chichester 57 125
20. E. Jantratid, V.D. Maio, E. Ronda, V. Mattavelli, M. Vertzoni, and J.B. Dressman Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form Eur. J. Pharm. Sci. 37 2009 434 441
21. L. Kabanda, R.A. Lefebvre, H.J.V. Bree, and J.P. Remon In vitro and in vivo evaluation in dogs and pigs of a hydrophilic matrix containing propylthiouracil Pharm. Res. 11 1994 1663 1668 (Pubitemid 24339691)
22. N.A. Kasim, M. Whitehouse, C. Ramachandran, M. Bermejo, H. Lennernas, A.S. Hussain, H.E. Junginger, S.A. Stavchansky, K.K. Midha, V.P. Shah, and G.L. Amidon Molecular properties of WHO essential drugs and provisional biopharmaceutical classification Mol. Pharm. 1 2004 85 96
23. N. Katori, N. Aoyagi, and T. Terao Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation Pharm. Res. 12 1995 237 243
24. M.J. Kendall, D.P. Thornhill, and J.V. Willis Factors affecting the pharmacokinetics of diclofenac sodium Rheumatol. Rehabil. Suppl. 2 1979 38 45
25. H.V. Kothari, W.H. Lee, and E.C. Ku An alternative mechanism for regulation of leukotriene production in leukocytes: studies with an anti-inflammatory drug, sodium diclofenac Biochim. Biophys. Acta 921 1987 502 511 (Pubitemid 17142289)
26. A.P. Kourounakis, D. Galanakis, K. Tsiakitzis, E.A. Rekka, and P.N. Kourounakis Synthesis and pharmacological evaluation of novel derivatives of anti-inflammatory drugs with increased antioxidant and anti-inflammatory activities Drug Dev. Res. 47 1999 9 16 (Pubitemid 29293568)
27. A. Kramar, S. Turk, and F. Vrecer Statistical optimization of diclofenac sustained release pellets coated with polymethacrylic films Int. J. Pharm. 256 2003 43 52 (Pubitemid 36412138)
28. E.C. Ku, H. Kothari, and W. Lee Effects of diclofenac sodium on arachidonic acid metabolism Agents Actions Suppl. 17 1985 189 193
29. G. Levy, J.R. Leonards, and J.A. Procknal Development of in vitro dissolution tests which correlate quantitatively with dissolution rate-limited drug absorption in man J. Pharm. Sci. 54 1963 1719 1722
30. J.W. McGinity Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms second ed. 1997 Marcel Dekker New York
31. P. Mojaverian, E. Radwanski, C.C. Lin, P. Cho, W.A. Vadino, and J.M. Rosen Correlation of in vitro release rate and in vivo absorption characteristics of four chlorpheniramine maleate extended-release formulations Pharm. Res. 9 1992 450 456
32. S.R. Muller-Lissner, and A.L. Blum The effect of specific gravity and eating on gastric emptying of slow release capsules N. Engl. J. Med. 304 1981 1365 1366
33. S. Murata, S. Ueda, F. Shimojo, Y. Tokunaga, T. Hata, and N. Ohnishi In vivo performance of time-controlled explosion system (TES) in GI physiology regulated dogs Int. J. Pharm. 161 1998 161 168 (Pubitemid 28095700)
34. S. Narisawa, M. Nagata, T. Ito, H. Yoshino, Y. Hirakawa, and K. Noda Drug release behavior in gastrointestinal tract of beagle dogs from multiple unit type rate-controlled release preparations coated with insoluble polymer-based films J. Control. Release 33 1995 253 260
35. T. Nishihata Simple formulation of sustained-release tablets of sodium diclofenac and examination in humans Int. J. Pharm. 40 1987 125 128
36. Novartis Prescribing Information of Cataflam 2005 Available from http://www.pharm.us.novartis.com/product/pi/pdf/Cataflam.pdf
37. Novartis Prescribing Information of Voltaren 2006 Available from http://www.pharm.us.novartis.com/product/pi/pdf/Voltaren.pdf
38. K.M. O'Connor, and O.I. Corrigan Preparation and characterization of a range of diclofenac salts Int. J. Pharm. 226 2001 163 179 (Pubitemid 32800791)
39. H. Ogata, T. Shibazaki, T. Inoue, and E. Ejima Dissolution system for chloramphenicol tablet bioavailability J. Pharm. Sci. 68 1979 712 715 (Pubitemid 9214377)
40. K. Park, and J.R. Robinson Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion Int. J. Pharm. 19 1984 107 127 (Pubitemid 14144031)
41. L.F. Prescott Clinical limitation of controlled-released dosage forms J. Urquhart, Controlled Release Pharmaceuticals 1981 Am Pharm Ass Washington 51 59
42. M. Rowland, and T.N. Tozer Clinical Pharmacokinetics 1980 Lea and Febiger Philadelphia pp. 16-33
43. A. Savaser, Y. Ozkan, and A. Isimer Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium IL Farmaco. 60 2005 171 177 (Pubitemid 40327022)
44. S. Su, C. Chou, C. Kung, and J. Huang In vitro and in vivo comparison of two diclofenac sodium sustained release oral formulations Int. J. Pharm. 260 2003 39 46 (Pubitemid 36724859)
45. M.S. Suleiman, N. Najib, Y. El-Sayed, M. Hasan, and M. Abdulhameed A study on the relative bioavailability of a sustained-release formulation of diclofenac sodium Int. J. Clin. Pharmacol. Ther. Toxicol. 27 1989 276 279 (Pubitemid 19147147)
46. Y. Sun, C. Chang, W. Huang, and H. Liang Fluidized-bed spray coated porous hydrogel beads for sustained release of diclofenac sodium J. Control. Release 47 1997 247 260 (Pubitemid 27220208)
47. P. Todd, and E. Sorkin Diclofenac sodium A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy Drugs 35 1988 244 285
48. T. Tshchiya, M. Terakawa, K. Ishibashi, H. Noguti, and R. Kato Disposition and enterohepatic circulation of diclofenac in dogs Arzneimittel-Forschung/Drug Res. 30 1980 1650 1653 (Pubitemid 10005522)
49. S. Ueda, R. Ibuki, A. Kawamura, S. Murata, T. Takahashi, S. Kimura, and T. Hata Development of a novel drug delivery system. Time-controlled explosion system (TES). IV. In vivo drug release behavior J. Drug Target. 2 1994 133 140 (Pubitemid 24194291)
50. S.P. Vyas, N.K. Jain, and S. Khanna Formulation and performance evaluation of controlled release diclofenac tablets J. Control. Release 10 1989 219 223 (Pubitemid 19259954)
51. S. Willmann, K. Thelen, C. Becker, J.B. Dressman, and J. Lippert Mechanism-based prediction of particle size-dependent dissolution and absorption: cilostazol pharmacokinetics in dogs Eur. J. Pharm. Biopharm. 76 2010 83 94
52. J.V. Willis, M.J. Kendall, and D.B. Jack The influence of food on the absorption of diclofenac after single and multiple oral doses Eur. J. Clin. Pharmacol. 19 1981 33 37 (Pubitemid 11197404)
53. J.V. Willis, M.J. Kendall, R.M. Flinn, D.P. Thornhill, and P.G. Welling The pharmacokinetics of diclofenac sodium following intravenous and oral administration Eur. J. Clin. Pharmacol. 16 1979 405 410 (Pubitemid 10173752)
54. L. Yang, and R. Fassihi Modulation of diclofenac release from a totally soluble controlled release drug delivery system J. Control. Release 44 1997 135 140 (Pubitemid 27039110)
55. K.H. Yuen, A.A. Desmukh, and J.M. Newton In vivo/in vitro correlation of experimental sustained-release theophylline formulations Pharm. Res. 10 1993 588 592 (Pubitemid 23113053)